{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:22:32Z","timestamp":1768620152270,"version":"3.49.0"},"reference-count":19,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>(1) Background: Constipation is one of the most serious adverse effects of potassium-lowering agents and decreases patients\u2019 quality of life. Sodium zirconium cyclosilicate (SZC) is a recently innovated potassium binder intended for patients with hyperkalemia. The impact of SZC on the worsening of constipation, as compared with conventional potassium binders, remains unknown. (2) Methods: Patients with hyperkalemia who continued SZC for over 3 months between July 2020 and May 2022 were included in this retrospective study. Patients who received other conventional potassium binders during the same period were included as a control group. Trends in the doses of anti-constipation agents during the 3-month therapeutic period were compared between the two groups as a surrogate for worsening constipation. (3) Results: A total of 50 patients (median age 74 years, 31 male) were included, consisting of 22 patients with SZC and 28 patients with other conventional potassium binders. All patients had hyperkalemia and chronic kidney disease at baseline. During the 3-month therapeutic period, serum potassium levels decreased significantly in both groups (p &lt; 0.05 for both). The number of anti-constipation remained unchanged in the SZC group but tended to increase in the control group (p = 0.56 and p = 0.090, respectively). The total dose change in all anti-constipations was significantly lower in the SZC group than in the control group (p = 0.037). (4) Conclusions: Conventional potassium binders have a tendency to worsen constipation, whereas SZC may have the potential to improve hyperkalemia without worsening constipation. SZC may be recommended, particularly in elderly patients with ongoing or high-risk constipation.<\/jats:p>","DOI":"10.3390\/jcm12185971","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:06:13Z","timestamp":1694750773000},"page":"5971","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders"],"prefix":"10.3390","volume":"12","author":[{"given":"Yuki","family":"Hida","sequence":"first","affiliation":[{"name":"Second Department of Medicine, University of Toyama, Toyama 930-0193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7294-7637","authenticated-orcid":false,"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"Second Department of Medicine, University of Toyama, Toyama 930-0193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"Second Department of Medicine, University of Toyama, Toyama 930-0193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2016.06.060","article-title":"Hyperkalemia in Heart Failure","volume":"68","author":"Sarwar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"iii12","DOI":"10.1093\/ndt\/gfz231","article-title":"Hyperkalemia in patients with chronic renal failure","volume":"34","author":"Seliger","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_3","first-page":"CD013165","article-title":"Potassium binders for chronic hyperkalaemia in people with chronic kidney disease","volume":"6","author":"Natale","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Narita, Y., Fukumoto, K., Fukunaga, M., Kondo, Y., Ishitsuka, Y., Jono, H., Irie, T., Saito, H., Kadowaki, D., and Hirata, S. (2020). Comparative Study of Constipation Exacerbation by Potassium Binders Using a Loperamide-Induced Constipation Model. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072491"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/jch.13489","article-title":"Constipation-induced pressor effects as triggers for cardiovascular events","volume":"21","author":"Ishiyama","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2016060656","article-title":"Constipation and Incident CKD","volume":"28","author":"Sumida","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1556\/2060.106.2019.19","article-title":"The gut-kidney-heart axis in chronic kidney disease","volume":"106","author":"Sumida","year":"2019","journal-title":"Physiol. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ekir.2019.11.002","article-title":"Constipation in CKD","volume":"5","author":"Sumida","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s40265-018-0991-6","article-title":"Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.12651018","article-title":"Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study","volume":"14","author":"Spinowitz","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_12","first-page":"54","article-title":"Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: The randomized, placebo-controlled HARMONIZE-Global study","volume":"7","author":"Zannad","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000504078","article-title":"Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE","volume":"50","author":"Roger","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: The HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656566.2015.1066334","article-title":"Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia","volume":"16","author":"Rafique","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Imamura, T., and Kinugawa, K. (2022). Successful Conversion from Conventional Potassium Binder to Sodium Zirconium Cyclosilicate in a Patient with Refractory Constipation. Medicina, 58.","DOI":"10.3390\/medicina58050635"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.mayocp.2020.06.014","article-title":"Clinical Management of Hyperkalemia","volume":"96","author":"Palmer","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Imamura, T., Fujioka, H., Narang, N., and Kinugawa, K. (2023). Impact of sodium zirconium cyclosilicate therapy on nutrition status in patients with hyperkalemia. J. Clin. Med., 12.","DOI":"10.3390\/jcm12010083"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MCG.0b013e31820fb914","article-title":"World Gastroenterology Organisation global guideline: Constipation\u2014A global perspective","volume":"45","author":"Lindberg","year":"2011","journal-title":"J. Clin. Gastroenterol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/18\/5971\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:51:03Z","timestamp":1760129463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/18\/5971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":19,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["jcm12185971"],"URL":"https:\/\/doi.org\/10.3390\/jcm12185971","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]}}}